Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)

The summary for the Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional): Funding Opportunity PurposeThe full-scale Diversity Centers for Genome Research (DCGR) program aims to establish Genomic Research Centers at Minority Serving Institutions (MSIs) as defined in Part 2, section III of the FOA. The MSIs must have a mission to serve historically underrepresented populations in biomedical research that award doctorate degrees in the health professions or the sciences related to health, and have received an average of less than $50 million per year in NIH support and less than $25 million per year of R01 total cost of NIH support for the past three fiscal years. The purpose of this FOA is to call for applications for UG3/UH3 cooperative agreements to support the development and planning for a multi-investigator, interdisciplinary team to develop administrative, genomic workforce development and community engagement cores and 2-3 interrelated, innovative genomic research projects that address one or more critical issues in genomics including: genomic technology and methods development; genome structure; genome function; genomics of disease; use and impact of genomic information in clinical care; genomic data science and computational genomics, ethical, legal, and social implications of genomic research (ELSI); and/or genomics and health equity. The outcome of the development and feasibility studies will be fully developed plans to carry out all activities of a full-scale Diversity Center for Genome Research. Along with its scientific goals, the DCGR should expand the pool of diverse genomic scientists, clinician scientists, and researchers who can perform innovative genomics research by providing didactic, practicum and research activities and experiences that are aligned with the research projects.
Federal Grant Title: Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HG-22-027
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.172, 93.242, 93.307
CFDA Descriptions: Information not provided
Current Application Deadline: June 24th, 2024
Original Application Deadline: June 24th, 2024
Posted Date: September 22nd, 2022
Creation Date: September 22nd, 2022
Archive Date: July 30th, 2024
Total Program Funding:
Maximum Federal Grant Award: $300,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: September 22nd, 2022
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-22-027.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required)
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Per...
Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Per...
Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Tr...
Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clini...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com